Efficacy and Safety of Tazarotene Gel in Nail Psoriasis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Key inclusion criteria:
Mild to moderate nail psoriasis on at least one fingernail
Key exclusion criteria:
any other skin condition, with a potential to affect the nails or to interfere with evaluation of the disease;
history of hypersensitivity to retinoids or to other components of the trial medication
topical treatment of nails with antipsoriatics in the 4 weeks preceding the treatment phase;
systemic treatment of psoriasis within the three months before the treatment phase of the trial or during the trial
intralesional steroid injection before the treatment phase of the trial
phototherapy before the treatment phase of the trial;
any chronic infection or condition capable of interfering with the conduct of the trial;
evidence of drug or alcohol abuse;
symptoms of a clinically significant illness that may influence the outcome of the trial in the four weeks preceding the treatment phase of the trial;
participation in another clinical trial within the last 4 weeks prior to first treatment in this clinical trial;